20 Fentanyl Citrate Solubility UK Websites That Are Taking The Internet By Storm

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This short article is planned for instructional and expert info functions only. Fentanyl citrate is a Class A regulated compound in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formula need to only be conducted by certified professionals in managed environments.

In the realm of pharmacology and medical medication, fentanyl citrate stays one of the most powerful artificial opioids readily available. Due to its high effectiveness and fast start of action, it is a cornerstone of discomfort management and anaesthesia in the UK's National Health Service (NHS) and private healthcare sectors. Nevertheless, the pharmacological effectiveness of any drug is inherently linked to its physicochemical homes-- particularly its solubility.

Comprehending the solubility of fentanyl citrate is crucial for pharmacists, scientists, and clinicians to ensure stable formulations, accurate dosing, and efficient drug delivery throughout various administration paths.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is highly lipophilic (fat-soluble), it has minimal solubility in liquid environments. By responding the base with citric acid, moving into the salt form (fentanyl citrate), the solubility in water is considerably boosted. learn more makes it ideal for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is made according to the standards set by the British Pharmacopoeia (BP). learn more appears as a white, crystalline powder or as granules that are odorless.

Key Physicochemical Properties

Residential or commercial property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Roughly 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate varies significantly depending


on the solvent utilized and the ambient temperature. In

a pharmaceutical setting, water is the main solvent of interest for injectables, but organic solvents are frequently used during the manufacturing of transdermal patches or nasal sprays. Liquid Solubility In the UK medical context, fentanyl citrate is most commonly come across as a 50 mcg/mL service for injection. At space temperature(approximately 20 ° C to 25 ° C), fentanyl

citrate is thought about"moderately soluble"in water. Scientific literature generally recommends a solubility limitation of approximately 25 mg/mL in water at 25 ° C, which is more than sufficient for standard scientific concentrations. Organic Solvent Solubility Fentanyl citrate shows different solubility in natural solvents, which is important for developing non-aqueous drug shipment systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Moderately Soluble ~ 25 mg/mL Methanol Freely Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol Slightly Soluble

<10 mg/mL Elements Influencing Solubility and Stability The solubility of fentanyl citrate is not a static value; it

is affected by a number of ecological and chemical aspects that should be managed throughout intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate stays extremely soluble in acidic to neutral solutions. A lot of UK-licensed fentanyl injections are buffered to a pH series of

4.0 to 7.5. Alkaline Environments: If the pH of an option increases significantly above 7.5, there is a danger that the fentanyl


will transition back into its base form. Due to the fact that the base

type is substantially less soluble in water, this can lead to"crashing out"or rainfall, which is very harmful in an IV setting. 2. Temperature Effects Like the majority of crystalline solids, the solubility of fentanyl citrate increases with temperature level. While this is handy during the industrial dissolution process, it positions a threat during storage . If a saturated service is prepared at a high temperature level and then cooled (such as throughout transport in cold UK winter seasons), the solute may take shape. 3. Existence of Other Ions(Common **Ion Effect )The presence of other citrate salts in the option can decrease the solubility of fentanyl citrate due to the common ion effect. This is a necessary consideration when mixing fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The option of buffer(e.g., salt citrate or phosphate buffers)is

important in maintaining a stable environment where the drug remains in its ionized, soluble kind. Formulating for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medical items should comply with the British Pharmacopoeia(BP). The BP provides specific monographs for Fentanyl Citrate, making sure purity, potency, and solubility standards are fulfilled. Key Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral options be clear and devoid of visible particles. This is accomplished by making sure the concentration stays well listed below the saturation point. Sterility: Given the liquid nature of the service, solutions must be

### sterilized, normally

via autoclaving or filtration, which can affect the stability if the solubility limits are tight. Excipients: Common additives in UK fentanyl formulations include Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH change). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the healthcare professional? Avoiding Precipitation: Knowing that fentanyl is incompatible with highly alkaline

**solutions(like thiopentone or some bicarbonate solutions

*   **)prevents the formation of precipitates that might trigger embolic events. Optimizing Drug Delivery: In the development of sublingual or buccal tablets (e.g., Abstral or Effentora used in the UK), the drug needs to liquify*   **quickly in the small volume of saliva offered. Transdermal Flux: While spots count on the lipophilicity of the fentanyl base, the manufacture of these spots often involves dissolving the citrate salt in an unpredictable solvent*   **before it is impregnated into the adhesive matrix. Storage and Handling Recommendations To preserve the solubility and efficacy of fentanyl citrate items, the following guidelines are normally

            * * *

            followed in British clinical settings: Temperature
            --------------------------------------------------

            Control: Store at controlled space temperature level (15 ° C to 25 ° C). Prevent freezing, as this can cause irreversible rainfall in**particular solutions. Light** Protection: Fentanyl citrate is somewhat light-sensitive. [Fentanyl Research Chemical UK](https://telegra.ph/Why-Is-It-So-Useful-In-COVID-19-05-24-8) need to be kept in amber glass or nontransparent packaging. Handling Potency: Because of its high solubility and effectiveness, unexpected skin contact*   **with focused solutions** can lead to systemic absorption. Expert PPE is obligatory. Regularly Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, substantially.
            *   **The citrate salt is created particularly to increase aqueous solubility, making it suitable for injections. The base form is highly lipophilic and is normally used in the internal layers of transdermal spots. Does the UK BP(British Pharmacopoeia)differ

                from the USP concerning solubility? The general

                solubility profiles equal as they explain the very same chemical entity. Nevertheless, the exact testing methods and the prioritized solvents for purity screening might differ

                *   **slightly between the BP** and the United States Pharmacopeia (USP). Can I blend fentanyl citrate with saline? Yes. Fentanyl citrate is compatible with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are basic diluents utilized in UK medical facilities. What happens if a fentanyl service becomes cloudy? If a solution of fentanyl citrate appears cloudy or includes** crystals, it should be disposed of. This indicates that the drug has actually precipitated out of the option, either due to pH modifications, temperature shifts, or contamination.

                * * *

                Why is citric acid used specifically?
                -------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade natural acid. It forms a steady salt with fentanyl that offers a balance of high water solubility and suitable pH for human tissue. Fentanyl citrate is a crucial medicinal tool in the UK, however its safety and effectiveness are predicated on

                ### its chemical stability. Solubility is maybe the most critical consider this regard

                . By keeping an optimal pH, picking the correct solvents, and adhering to British Pharmacopoeia requirements, the pharmaceutical industry ensures that this potent analgesic remains a dependable alternative for client care.

                ### For clinicians, the takeaway is easy: always verify compatibility before mixing and make sure storage conditions are strictly satisfied to prevent the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 24 May 2026 15:58 UTC

Views: 3